Close

Publications

RISK11 signature scores for the biomarker-guided tuberculosis preventive therapy (CORTIS) randomised controlled trial.
Scriba, TJ; Fiore-Gartland, A; Penn-Nicholson, A; Mulenga, H; Kimbung Mbandi, S; Borate, B; Mendelsohn, SC; Hadley, K; Hikuam, C; Kaskar, M; Musvosvi, M; Bilek, N; Self, S; SUMNER, T; WHITE, RG; Erasmus, M; Jaxa, L; Raphela, R; Innes, C; Brumskine, W; Hiemstra, A; Malherbe, ST; Hassan-Moosa, R; Tameris, M; Walzl, G; ... Hatherill, M.
2021
, University of Cape Town (2021).
Pollara, G; Turner, CT; Rosenheim, J; Chandran, A; Bell, LC K; Khan, A; Patel, A; Peralta, LF; Folino, A; Akarca, A; Venturini, C; Baker, T; Ecker, S; Ricciardolo, FL M; Marafioti, T; Ugarte-Gil, C; MOORE, DA J; Chain, BM; Tomlinson, GS; Noursadeghi, M;
2021
SCIENCE TRANSLATIONAL MEDICINE, (2021).13 592 10.1126/scitranslmed.abg7673.
Torres Ortiz, A; Coronel, J; Vidal, JR; Bonilla, C; MOORE, DA J; Gilman, RH; Balloux, F; Kon, OM; Didelot, X; Grandjean, L;
2021
Nature Communications, (2021).12 1 10.1038/s41467-021-27616-7.
Ntshiqa, T; Chihota, V; MANSUKHANI, R; Nhlangulela, L; Velen, K; Charalambous, S; Maenetje, P; Hawn, T; Wallis, R; GRANT, A; Fielding, K; Churchyard, G;
2021
Gates Open Research, (2021).5, 10.12688/gatesopenres.13191.1.
CALDERWOOD, CJ; Wilson, JP; FIELDING, KL; Harris, RC; Karat, AS; MANSUKHANI, R; FALCONER, J; Bergstrom, M; Johnson, SM; MCCREESH, N; Monk, EJ M; Odayar, J; Scott, PJ; Stokes, SA; Theodorou, H; MOORE, DA J;
2021
PLoS medicine, (2021).18 4 10.1371/journal.pmed.1003566.
Kielmann, K; Dickson-Hall, L; Jassat, W; Le Roux, S; Moshabela, M; Cox, H; GRANT, AD; Loveday, M; Hill, J; Nicol, MP; Mlisana, K; Black, J;
2021
Health policy and planning, (2021).36 3 10.1093/heapol/czaa147.
Reza, TF; Nalugwa, T; Nantale, M; Adams, K; FIELDING, K; Nakaweesa, A; Oyuku, D; Nabwire, S; Musinguzi, J; Ojok, C; Babirye, D; Ackerman, SL; Handley, MA; Kityamuwesi, A; Dowdy, DW; MOORE, DA J; Davis, JL; Turyahabwe, S; Katamba, A; Cattamanchi, A;
2021
Contemporary clinical trials communications, (2021).22, 10.1016/j.conctc.2021.100707.
Where will it end? Pathways to care and catastrophic costs following negative TB evaluation in Uganda. Raw data for analysis.
Samuels, TH A; Shete, PB; Ojok, C; Nalugwa, T; Farr, K; Turyahabwe, S; Katamba, A; Cattamanchi, A; MOORE, DA J;
2021
, PLOS One (2021).